Clinical Trial Update: A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer [Phase 4]

View source ↗

Summary

Takeda is conducting a Phase 4 trial to evaluate the safety and activity of fruquintinib in minority populations with advanced, previously treated colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Phase 4 | Status: RECRUITING